Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | %Female (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Phytotaxa | journal | 2.363 Q1 | 49 | 201 | 19 | 6892 | 85 | 16 | 4.47 | 34.29 | 26.59 | |
2 | International Journal of COPD | journal | 1.145 Q1 | 88 | 85 | 172 | 2653 | 543 | 168 | 2.76 | 31.21 | 33.59 | |
3 | Drug Design, Development and Therapy | journal | 1.089 Q1 | 94 | 43 | 93 | 1938 | 437 | 93 | 5.24 | 45.07 | 28.49 | |
4 | New Zealand Journal of Ecology | journal | 1.052 Q1 | 56 | 47 | 93 | 2220 | 200 | 92 | 2.25 | 47.23 | 37.82 | |
5 | International Journal of Nanomedicine | journal | 1.041 Q1 | 179 | 519 | 479 | 22168 | 2054 | 479 | 4.09 | 42.71 | 38.57 | |
6 | Clinical Epidemiology | journal | 1.014 Q2 | 78 | 54 | 79 | 1646 | 232 | 74 | 2.94 | 30.48 | 38.86 | |
7 | Biologics: Targets and Therapy | journal | 0.845 Q2 | 47 | 46 | 67 | 3347 | 202 | 66 | 3.11 | 72.76 | 44.37 | |
8 | Clinical Interventions in Aging | journal | 0.836 Q1 | 104 | 68 | 137 | 2808 | 484 | 135 | 3.75 | 41.29 | 32.33 | |
9 | Vascular Health and Risk Management | journal | 0.806 Q2 | 82 | 73 | 316 | 3285 | 934 | 312 | 2.67 | 45.00 | 27.30 | |
10 | OncoTargets and Therapy | journal | 0.805 Q2 | 86 | 51 | 64 | 2641 | 152 | 64 | 3.12 | 51.78 | 37.08 | |
11 | Breast Cancer: Basic and Clinical Research | journal | 0.795 Q2 | 35 | 16 | 46 | 694 | 111 | 44 | 2.40 | 43.38 | 44.44 | |
12 | Cancer Management and Research | journal | 0.770 Q2 | 67 | 47 | 63 | 2398 | 161 | 63 | 2.56 | 51.02 | 41.62 | |
13 | Core Evidence (discontinued) | journal | 0.725 Q1 | 29 | 12 | 38 | 757 | 102 | 36 | 2.41 | 63.08 | 16.67 | |
14 | Neuropsychiatric Disease and Treatment | journal | 0.695 Q2 | 91 | 89 | 169 | 3755 | 411 | 148 | 2.25 | 42.19 | 35.71 | |
15 | Nanotechnology, Science and Applications | journal | 0.689 Q1 | 35 | 8 | 27 | 480 | 82 | 27 | 3.04 | 60.00 | 27.59 | |
16 | Journal of Receptor, Ligand and Channel Research | journal | 0.676 Q2 | 13 | 2 | 10 | 44 | 25 | 9 | 2.50 | 22.00 | 33.33 | |
17 | Bulletin of the New Zealand Society for Earthquake Engineering | journal | 0.674 Q1 | 41 | 19 | 92 | 464 | 121 | 90 | 1.65 | 24.42 | 13.89 | |
18 | Clinical Ophthalmology | journal | 0.662 Q2 | 78 | 316 | 614 | 7705 | 905 | 611 | 1.38 | 24.38 | 28.66 | |
19 | Biomarker Insights | journal | 0.648 Q2 | 40 | 16 | 53 | 759 | 128 | 53 | 2.47 | 47.44 | 44.05 | |
20 | Bioinformatics and Biology Insights | journal | 0.638 Q2 | 32 | 23 | 29 | 1058 | 54 | 29 | 1.76 | 46.00 | 25.30 | |
21 | Infection and Drug Resistance | journal | 0.614 Q2 | 65 | 20 | 33 | 953 | 63 | 31 | 2.07 | 47.65 | 39.29 | |
22 | Zootaxa | journal | 0.595 Q2 | 103 | 1885 | 4684 | 70394 | 4557 | 4541 | 0.97 | 37.34 | 25.22 | |
23 | Patient Preference and Adherence | journal | 0.590 Q1 | 67 | 94 | 141 | 3847 | 269 | 138 | 1.97 | 40.93 | 44.57 | |
24 | International Journal of Women's Health | journal | 0.540 Q1 | 64 | 72 | 122 | 2921 | 264 | 119 | 2.23 | 40.57 | 44.22 | |
25 | Evolutionary Bioinformatics | journal | 0.530 Q2 | 38 | 32 | 75 | 1465 | 96 | 75 | 1.56 | 45.78 | 27.62 | |
26 | Therapeutics and Clinical Risk Management | journal | 0.516 Q1 | 70 | 47 | 127 | 2311 | 281 | 127 | 2.27 | 49.17 | 28.40 | |
27 | New Zealand Plant Protection | journal | 0.513 Q2 | 26 | 46 | 151 | 780 | 106 | 149 | 0.60 | 16.96 | 45.19 | |
28 | Journal of Pain Research | journal | 0.478 Q2 | 71 | 62 | 69 | 2781 | 118 | 69 | 1.74 | 44.85 | 36.40 | |
29 | International Journal of Tryptophan Research | journal | 0.466 Q3 | 33 | 2 | 31 | 59 | 44 | 29 | 0.76 | 29.50 | 15.38 | |
30 | Clinical Medicine Insights: Oncology | journal | 0.452 Q3 | 33 | 44 | 61 | 2616 | 96 | 61 | 1.65 | 59.45 | 28.05 | |
31 | HIV/AIDS - Research and Palliative Care | journal | 0.452 Q2 | 32 | 21 | 29 | 806 | 41 | 29 | 1.41 | 38.38 | 33.33 | |
32 | Diabetes, Metabolic Syndrome and Obesity | journal | 0.447 Q2 | 64 | 42 | 51 | 2393 | 84 | 50 | 2.28 | 56.98 | 48.06 | |
33 | Journal of Experimental Neuroscience | journal | 0.416 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
34 | Cancer Informatics | journal | 0.387 Q3 | 37 | 15 | 78 | 514 | 86 | 74 | 1.19 | 34.27 | 22.92 | |
35 | Journal of Inflammation Research | journal | 0.382 Q3 | 51 | 17 | 28 | 664 | 37 | 28 | 1.32 | 39.06 | 31.96 | |
36 | Perspectives in Medicinal Chemistry | journal | 0.382 Q2 | 17 | 0 | 8 | 0 | 13 | 8 | 0.60 | 0.00 | 0.00 | |
37 | International Journal of General Medicine (discontinued) | journal | 0.379 Q2 | 52 | 136 | 124 | 4542 | 190 | 123 | 1.67 | 33.40 | 29.67 | |
38 | Drug, Healthcare and Patient Safety | journal | 0.375 Q2 | 30 | 17 | 51 | 826 | 64 | 49 | 1.22 | 48.59 | 27.27 | |
39 | Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders | journal | 0.360 Q3 | 27 | 11 | 25 | 441 | 39 | 25 | 1.81 | 40.09 | 11.11 | |
40 | Clinical Medicine Insights: Cardiology | journal | 0.357 Q3 | 33 | 20 | 53 | 662 | 51 | 50 | 0.90 | 33.10 | 25.93 | |
41 | ClinicoEconomics and Outcomes Research | journal | 0.353 Q2 | 39 | 43 | 45 | 1489 | 53 | 44 | 1.40 | 34.63 | 31.35 | |
42 | Cell Health and Cytoskeleton | journal | 0.347 Q3 | 16 | 10 | 11 | 1290 | 13 | 10 | 1.18 | 129.00 | 40.00 | |
43 | New Zealand Medical Journal | journal | 0.338 Q3 | 58 | 360 | 1149 | 5288 | 613 | 791 | 0.44 | 14.69 | 44.06 | |
44 | Social Behavior and Personality | journal | 0.336 Q3 | 75 | 168 | 392 | 4271 | 320 | 391 | 0.68 | 25.42 | 44.85 | |
45 | International Journal of Wine Research (discontinued) | journal | 0.315 Q3 | 19 | 6 | 40 | 242 | 36 | 33 | 0.28 | 40.33 | 37.50 | |
46 | Journal of Asthma and Allergy | journal | 0.313 Q3 | 41 | 10 | 43 | 323 | 54 | 42 | 1.35 | 32.30 | 46.51 | |
47 | Gene Regulation and Systems Biology | journal | 0.302 Q3 | 22 | 11 | 25 | 522 | 27 | 25 | 0.95 | 47.45 | 20.00 | |
48 | Advances and Applications in Bioinformatics and Chemistry | journal | 0.292 Q3 | 19 | 5 | 29 | 170 | 17 | 26 | 0.50 | 34.00 | 31.58 | |
49 | Notornis | journal | 0.290 Q3 | 25 | 30 | 111 | 756 | 40 | 105 | 0.19 | 25.20 | 17.39 | |
50 | Fluoride - Quarterly Reports | journal | 0.288 Q2 | 51 | 45 | 114 | 1115 | 131 | 106 | 1.03 | 24.78 | 46.02 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®